These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37404820)

  • 1. Case Report: Chronic hepatitis E virus Infection in an individual without evidence for immune deficiency.
    Ying D; Niu W; Chen Y; Wang Y; Tian W; Zhang X; Liu C; Wang S; Chen Z; Lin Y; Guo S; Yu Z; Chen X; Fang M; Qiang H; Yin Y; Tang Z; Zheng Z; Fu L; Xia N
    Front Immunol; 2023; 14():1183859. PubMed ID: 37404820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
    Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
    J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of CD8+ T-cell failure in chronic hepatitis E virus infection.
    Kemming J; Gundlach S; Panning M; Huzly D; Huang J; Lütgehetmann M; Pischke S; Schulze Zur Wiesch J; Emmerich F; Llewellyn-Lacey S; Price DA; Tanriver Y; Warnatz K; Boettler T; Thimme R; Hofmann M; Fischer N; Neumann-Haefelin C
    J Hepatol; 2022 Oct; 77(4):978-990. PubMed ID: 35636577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus infection and fulminant hepatic failure during pregnancy.
    Jilani N; Das BC; Husain SA; Baweja UK; Chattopadhya D; Gupta RK; Sardana S; Kar P
    J Gastroenterol Hepatol; 2007 May; 22(5):676-82. PubMed ID: 17444855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques.
    Bremer W; Blasczyk H; Yin X; Salinas E; Grakoui A; Feng Z; Walker C
    J Hepatol; 2021 Sep; 75(3):557-564. PubMed ID: 33961939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
    Cao D; Cao QM; Subramaniam S; Yugo DM; Heffron CL; Rogers AJ; Kenney SP; Tian D; Matzinger SR; Overend C; Catanzaro N; LeRoith T; Wang H; Piñeyro P; Lindstrom N; Clark-Deener S; Yuan L; Meng XJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6914-6923. PubMed ID: 28630341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection.
    Colson P; Dhiver C; Gérolami R
    Clin Microbiol Infect; 2008 Dec; 14(12):1176-80. PubMed ID: 19046170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct disease features of acute and persistent genotype 3 hepatitis E virus infection in immunocompetent and immunosuppressed Mongolian gerbils.
    Subramaniam S; Fares-Gusmao R; Sato S; Cullen JM; Takeda K; Farci P; McGivern DR
    PLoS Pathog; 2023 Sep; 19(9):e1011664. PubMed ID: 37703304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection.
    Csernalabics B; Marinescu MS; Maurer L; Kelsch L; Werner J; Baumann K; Zoldan K; Panning M; Reuken P; Bruns T; Bengsch B; Neumann-Haefelin C; Hofmann M; Thimme R; Dao Thi VL; Boettler T
    J Hepatol; 2024 Apr; 80(4):564-575. PubMed ID: 38154741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8
    Rogers E; Todd SM; Pierson FW; Kenney SP; Heffron CL; Yugo DM; Matzinger SR; Mircoff E; Ngo I; Kirby C; Jones M; Siegel P; Jobst P; Hall K; Etches RJ; Meng XJ; LeRoith T
    J Med Virol; 2019 Nov; 91(11):1960-1969. PubMed ID: 31317546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection.
    Suneetha PV; Pischke S; Schlaphoff V; Grabowski J; Fytili P; Gronert A; Bremer B; Markova A; Jaroszewicz J; Bara C; Manns MP; Cornberg M; Wedemeyer H
    Hepatology; 2012 Mar; 55(3):695-708. PubMed ID: 22006345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis E virus infection in patients infected with the human immunodeficiency virus.
    Kaba M; Richet H; Ravaux I; Moreau J; Poizot-Martin I; Motte A; Nicolino-Brunet C; Dignat-George F; Ménard A; Dhiver C; Brouqui P; Colson P
    J Med Virol; 2011 Oct; 83(10):1704-16. PubMed ID: 21837786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Chronic hepatitis E in a hematopoietic stem cell transplant recipient: The first report of hepatitis E virus genotype 4 causing chronic infection in a non-solid organ recipient.
    Chen Z; Wei J; Jiang L; Ying D; Tian W; Zhang M; Wen G; Wang S; Liu C; Wang Y; Wu T; Tang Z; Zheng Z; Yan L; Xia N
    Front Immunol; 2022; 13():954697. PubMed ID: 36275730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Specificity, Functionality, and Durability of Host T-Cell Responses Against the Full-Length Hepatitis E Virus.
    Brown A; Halliday JS; Swadling L; Madden RG; Bendall R; Hunter JG; Maggs J; Simmonds P; Smith DB; Vine L; McLaughlin C; Collier J; Bonsall D; Jeffery K; Dunachie S; Klenerman P; Izopet J; Kamar N; Dalton HR; Barnes E
    Hepatology; 2016 Dec; 64(6):1934-1950. PubMed ID: 27631819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief communication: case reports of ribavirin treatment for chronic hepatitis E.
    Mallet V; Nicand E; Sultanik P; Chakvetadze C; Tessé S; Thervet E; Mouthon L; Sogni P; Pol S
    Ann Intern Med; 2010 Jul; 153(2):85-9. PubMed ID: 20547886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Course of HEV viremia and anti-HEV IgM/IgG response in asymptomatic blood donors.
    Kraef C; Schlein C; Hiller J; Westhölter D; Denzer U; Horvatits T; Peine S; Lohse AW; Lütgehetmann M; Polywka S; Pischke S
    J Clin Virol; 2018 Aug; 105():26-30. PubMed ID: 29860111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunobiology and Host Response to HEV.
    Zhou Y
    Adv Exp Med Biol; 2016; 948():113-141. PubMed ID: 27738982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection.
    Elkady A; Tanaka Y; Kurbanov F; Hirashima N; Sugiyama M; Khan A; Kato H; Okumura A; Mizokami M
    J Gastroenterol; 2007 Nov; 42(11):911-7. PubMed ID: 18008036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of active hepatitis E virus infection and efficacy of ribavirin treatment in renal allograft recipients.
    Friebus-Kardash J; Eisenberger U; Ackermann J; Kribben A; Witzke O; Wenzel J; Rohn H; Fiedler M
    Transpl Infect Dis; 2019 Jun; 21(3):e13088. PubMed ID: 30929308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.